Browse by author
Lookup NU author(s): Dr Emma Vardy
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
Alkaline phosphatase is present on neuronal membranes and plasma alkaline phosphatase activity increases in brain injury and cerebrovascular disease, suggesting that plasma alkaline phosphatase may partly reflect neuronal loss. As neuronal loss occurs in Alzheimer's disease (AD), we hypothesised that alterations in plasma alkaline phosphatase activity may correlate with cognitive impairment. Plasma alkaline phosphatase activity was measured in the longitudinal Oxford Project to Investigate Memory and Aging (OPTIMA) cohort (121 AD patients, 89 mild cognitive impairment (MCI) patients and 180 control subjects). Plasma alkaline phosphatase activity was significantly higher in the AD patients relative to the controls (p<0.001). In the MCI patients, plasma alkaline phosphatase was at a level in between that seen in control and AD subjects, consistent with the clinical status of this group. Furthermore, plasma alkaline phosphatase activity inversely correlated with cognitive function (assessed by the Cambridge Examination for Mental Disorders (CAMC0G)) in controls (z= −2.21 p=0.027), MCI (z= −2.49, p=0.013) and AD patients (z= −3.61, p=0.0003). These data indicate that plasma alkaline phosphatase activity is increased in AD and inversely correlates with cognitive function regardless of diagnostic status.
Author(s): Kellett KAB, Williams J, Vardy ERLC, Smith AD, Hooper NM
Publication type: Article
Publication status: Published
Journal: International Journal of Molecular Epidemiology and Genetics
Print publication date: 10/02/2011
ISSN (electronic): 1948-1756
Publisher: E-Century Publishing Corporation